513 related articles for article (PubMed ID: 35456705)
1. Effect of Solvents, Stabilizers and the Concentration of Stabilizers on the Physical Properties of Poly(d,l-lactide-
Alkholief M; Kalam MA; Anwer MK; Alshamsan A
Pharmaceutics; 2022 Apr; 14(4):. PubMed ID: 35456705
[TBL] [Abstract][Full Text] [Related]
2. Brigatinib loaded poly(d,l-lactide-co-glycolide) nanoparticles for improved anti-tumoral activity against non-small cell lung cancer cell lines.
Ahmed MM; Fatima F; Anwer MK; Aldawsari MF; Bhatia S; Al-Harrasi A
Drug Dev Ind Pharm; 2021 Jul; 47(7):1112-1120. PubMed ID: 34551665
[TBL] [Abstract][Full Text] [Related]
3. Formulation and evaluation of PLGA nanoparticles loaded capecitabine for prostate cancer.
Sun SB; Liu P; Shao FM; Miao QL
Int J Clin Exp Med; 2015; 8(10):19670-81. PubMed ID: 26770631
[TBL] [Abstract][Full Text] [Related]
4. Preparation, evaluation, and
Pan X; Liu S; Ju L; Xi J; He R; Zhao Y; Zhuang R; Huang J
Drug Dev Ind Pharm; 2020 Nov; 46(11):1889-1897. PubMed ID: 32975456
[TBL] [Abstract][Full Text] [Related]
5. Poly(lactic acid)-poly(ethylene glycol) nanoparticles as new carriers for the delivery of plasmid DNA.
Perez C; Sanchez A; Putnam D; Ting D; Langer R; Alonso MJ
J Control Release; 2001 Jul; 75(1-2):211-24. PubMed ID: 11451511
[TBL] [Abstract][Full Text] [Related]
6. PLGA nanoparticles for oral delivery of hydrophobic drugs: influence of organic solvent on nanoparticle formation and release behavior in vitro and in vivo using estradiol as a model drug.
Sahana DK; Mittal G; Bhardwaj V; Kumar MN
J Pharm Sci; 2008 Apr; 97(4):1530-42. PubMed ID: 17722098
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin.
Liu R; Wang Y; Li X; Bao W; Xia G; Chen W; Cheng J; Xu Y; Guo L; Chen B
Drug Des Devel Ther; 2015; 9():2705-19. PubMed ID: 26045659
[TBL] [Abstract][Full Text] [Related]
8. Preparation and in vitro evaluation of meloxicam-loaded PLGA nanoparticles on HT-29 human colon adenocarcinoma cells.
Şengel-Türk CT; Hasçiçek C; Dogan AL; Esendagli G; Guc D; Gönül N
Drug Dev Ind Pharm; 2012 Sep; 38(9):1107-16. PubMed ID: 22348284
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Nisin-Loaded PLGA Nanoparticles Prepared with Rhamnolipid Cosurfactant against
Üstün A; Örtücü S
Pharmaceutics; 2022 Dec; 14(12):. PubMed ID: 36559250
[TBL] [Abstract][Full Text] [Related]
10. Naringin as Sustained Delivery Nanoparticles Ameliorates the Anti-inflammatory Activity in a Freund's Complete Adjuvant-Induced Arthritis Model.
Mohanty S; Konkimalla VB; Pal A; Sharma T; Si SC
ACS Omega; 2021 Nov; 6(43):28630-28641. PubMed ID: 34746558
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, characterization, and evaluation of paclitaxel loaded in six-arm star-shaped poly(lactic-co-glycolic acid).
Chen Y; Yang Z; Liu C; Wang C; Zhao S; Yang J; Sun H; Zhang Z; Kong D; Song C
Int J Nanomedicine; 2013; 8():4315-26. PubMed ID: 24235829
[TBL] [Abstract][Full Text] [Related]
12. [Formulation and process optimization of doxorubicin-loaded PLGA nanoparticles and its in vitro release].
Li JL; Zheng CL; Liu JP; Zhu JB
Yao Xue Xue Bao; 2013 May; 48(5):759-66. PubMed ID: 23888702
[TBL] [Abstract][Full Text] [Related]
13. Sorafenib and Piperine co-loaded PLGA nanoparticles: Development, characterization, and anti-cancer activity against hepatocellular carcinoma cell line.
Alhudaithi SS; Abul Kalam M; Binobaid L; Ali R; Almutairi MM; Qamar W; Bin Hithlayn H; Almutairi A; Alshememry AK
Saudi Pharm J; 2024 May; 32(5):102064. PubMed ID: 38633710
[TBL] [Abstract][Full Text] [Related]
14. Development of biodegradable nanoparticles for oral delivery of ellagic acid and evaluation of their antioxidant efficacy against cyclosporine A-induced nephrotoxicity in rats.
Sonaje K; Italia JL; Sharma G; Bhardwaj V; Tikoo K; Kumar MN
Pharm Res; 2007 May; 24(5):899-908. PubMed ID: 17377747
[TBL] [Abstract][Full Text] [Related]
15. Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake.
Sahoo SK; Panyam J; Prabha S; Labhasetwar V
J Control Release; 2002 Jul; 82(1):105-14. PubMed ID: 12106981
[TBL] [Abstract][Full Text] [Related]
16. Novel docetaxel-loaded nanoparticles based on poly(lactide-co-caprolactone) and poly(lactide-co-glycolide-co-caprolactone) for prostate cancer treatment: formulation, characterization, and cytotoxicity studies.
Sanna V; Roggio AM; Posadino AM; Cossu A; Marceddu S; Mariani A; Alzari V; Uzzau S; Pintus G; Sechi M
Nanoscale Res Lett; 2011 Mar; 6(1):260. PubMed ID: 21711774
[TBL] [Abstract][Full Text] [Related]
17. Preparation, in vitro and in vivo evaluation of mPEG-PLGA nanoparticles co-loaded with syringopicroside and hydroxytyrosol.
Guan Q; Sun S; Li X; Lv S; Xu T; Sun J; Feng W; Zhang L; Li Y
J Mater Sci Mater Med; 2016 Feb; 27(2):24. PubMed ID: 26704541
[TBL] [Abstract][Full Text] [Related]
18. Lipid-PLGA hybrid nanoparticles of paclitaxel: Preparation, characterization, in vitro and in vivo evaluation.
Godara S; Lather V; Kirthanashri SV; Awasthi R; Pandita D
Mater Sci Eng C Mater Biol Appl; 2020 Apr; 109():110576. PubMed ID: 32228957
[TBL] [Abstract][Full Text] [Related]
19. Development of dry powder inhaler containing tadalafil-loaded PLGA nanoparticles.
Varshosaz J; Taymouri S; Hamishehkar H; Vatankhah R; Yaghubi S
Res Pharm Sci; 2017 Jun; 12(3):222-232. PubMed ID: 28626480
[TBL] [Abstract][Full Text] [Related]
20. Formulation and
Jonderian A; Maalouf R
Front Pharmacol; 2016; 7():458. PubMed ID: 27999542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
